Company / Free Cash Flow
Tango Therapeutics, Inc. Free Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$139.9M
FY2025
5-year range
-$139.9M / $69.0M
FY2021-FY2025
Trend
-5.8%
vs FY2024
Sector context
#126 of 194
Health Care
What the data says
At -$140M, Tango Therapeutics, Inc.'s free cash flow ranks #126 of 194 in the Health Care sector. Free Cash Flow has declined for 4 consecutive years, from $69M in FY2021 to -$140M in FY2025.
Based on SEC 10-K filings.
-$140M in FY2025.
Declined from -$120M to -$140M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 194 in Health CareTop 65% of 194This company -$139.9M Sector average $470.6M
▼
-129.7% below sector average
Key checks
Key Insights
- Tango Therapeutics, Inc.'s free cash flow has declined for 4 consecutive years.
- In FY2025, free cash flow decreased 5.8% year-over-year.
- Ranks #126 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$139.9M | -5.8% |
| FY2024 | -$132.3M | -10.7% |
| FY2023 | -$119.5M | -94.8% |
| FY2022 | -$61.4M | -189.0% |
| FY2021 | $69.0M | +0.0% |
| FY2020 | $69.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026